Home » AIDS TRIALS FACE UNCERTAIN FUTURE

AIDS TRIALS FACE UNCERTAIN FUTURE

June 7, 1994

No Comments

-- Lisa Piercey Washington Editor TEXT: WASHINGTON _ News reports about

Article reprints

BioWorld MedTech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 15, 2024.
After the first approvals, where does amyloid go from here?
BioWorld
After decades of trying and dozens of failed trials, amyloid targeting has paid off with the first disease-modifying agents reaching the market. But success does...
Labcorp to pay Opko $237.5M for select Bioreference assets
BioWorld MedTech
Laboratory Corporation of America Holdings Inc. agreed to purchase select assets of Bioreference Health from Opko Health Inc. for $237.5 million in a deal slated...
Aging, and aging well, gives clues for dementia drug discovery
BioWorld
Ironically, the first person to be diagnosed with what is now Alzheimer’s disease was missing its major risk factor. When she first began showing symptoms of...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe

Upgrade your daily dose of biopharma and medtech news

AIDS TRIALS FACE UNCERTAIN FUTURE